Fragrance allergy increases with age

W. Uter,A. Schnuch

DOI: https://doi.org/10.1111/j.1365-2133.2004.05968.x

IF: 11.113

2004-06-01

British Journal of Dermatology

Abstract:that this particular elderly subject was receiving a serotonin reuptake inhibitor for depression. The overall reduction in LC density in the elderly cohort is in agreement with our previous observations, and is indicative of a general decline in epidermal LC frequency with age. These results represent a significant decline in baseline LC frequencies of 23% (P < 0Æ001; Student’s t-test) in our elderly cohort (Fig. 1). Compared with saline controls, exposure to IL-1b resulted in a significant (P < 0Æ01; analysis of variance) decrease in LC frequency in the skin of both young and aged donors: reductions of 16% and 22%, respectively. This proportion of LCs that became mobilized is similar to the fraction of cells that migrate in response to other stimuli, including allergen, and is possibly a reflection of the variable differentiation status of epidermal LCs. The extent of the reduction in LC frequency was not significantly different between young and aged individuals, but was if anything more pronounced in aged skin. LCs displayed an activated phenotype, including extended dendritic processes and enhanced cell size in both young and aged skin in response to IL-1b similar to that published previously for other normal volunteers. We have reported previously that migration of LCs in response to TNF-a is significantly impaired in elderly subjects, with a 23% reduction in LC numbers being observed in response to local TNF-a in young volunteers, compared with only a 9% decrease in LC numbers in the elderly. In contrast, we report here that responses stimulated by similar exposure to IL-1b are unimpaired in the elderly. The implications are twofold: (i) there is no generalized inhibition of LC motility per se in aged skin, and (ii) the impaired motility of LCs in aged skin in response to TNF-a may be secondary to a reduced local availability of bioactive IL-1b. These findings are consistent with previous studies performed in mice. The available evidence indicates that IL-1b provides one signal for migration via type 1 IL-1 receptors expressed by LCs, and that this cytokine also stimulates the production by keratinocytes of TNF-a which then acts in paracrine fashion on adjacent LCs (via type 2 TNF receptors) to provide a second stimulus for mobilization. Given that LC migration in response to exogenous IL-1b is not compromised in aged skin, we hypothesize that impaired LC migration observed in response to TNF-a in elderly subjects is not attributable to decreased responsiveness to TNF-a per se, but due instead to inadequate bioactive IL-1b signalling. This may reflect either reduced transcription and ⁄ or translation of IL-1b by epidermal LCs overall, or on a per cell basis. Alternatively, compromised conversion of the IL-1b precursor molecule to the bioactive cytokine, or an increase in the relative availability of the antagonist, IL-1 receptor may provide alternative explanations. These data give further insights into the senescence of the skin immune system, in particular the effect of ageing on the number and functional characteristics of human epidermal LCs, and may be of clinical relevance in the impaired response to cutaneous infection and malignancy with age. M . B h u s h a n M . C u m b e r b a t c h * R . J . D e a r m a n * I . K i m b e r * C . E . M . G r i f f i t h s Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K. Correspondence: Professor C.E.M.Griffiths. E-mail: christopher.griffiths@ man.ac.uk